INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 45m ago
HOUSE PTR4m ago
SEC 13F4m ago
ROBINHOOD CHAIN4m ago
Public company

TLPHTALPHERA, INC.

CIK 0001427925

EDGAR filingsOpen in network
Disclosed transactions11
Buys / sells2 / 0
Max Insider Score51
Connections6with evidence

TLPH · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
BM
Bozilenko MarinaDirector
TLPHTALPHERA, INC.
Grant or award
A—
30.7K sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Jain AbhinavDirector · Jun 24, 2026
  • ← Insider ofevidence
    Bozilenko MarinaDirector · Jun 24, 2026
  • ← Insider ofevidence
    Todisco JosephDirector · Jun 24, 2026
  • ← Insider ofevidence
21
JA
Jain AbhinavDirector
TLPHTALPHERA, INC.
Grant or award
A
—
5,100 sh
Jun 22, 2026
Jun 24, 2026
traded Jun 22, 2026
+2d
SEC FORM 4

Evidence

21
BM
Bozilenko MarinaDirector
TLPHTALPHERA, INC.
Grant or award
A—
5,100 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

21
TJ
Todisco JosephDirector
TLPHTALPHERA, INC.
Grant or award
A—
5,100 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

9
TJ
Todisco JosephDirector
TLPHTALPHERA, INC.
Grant or award
A—
30.7K sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

9
JA
Jain AbhinavDirector
TLPHTALPHERA, INC.
Grant or award
A—
30.7K sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

9
AS
Aslam ShakilChief Medical Officer
TLPHTALPHERA, INC.
Tax withholding
F$3,723
4,518 sh
May 20, 2026May 21, 2026
traded May 20, 2026
+1dSEC FORM 4

Evidence

5
AS
Aslam ShakilChief Medical Officer
TLPHTALPHERA, INC.
Tax withholding
F$1,530
2,118 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC FORM 4

Evidence

50
AJ
Angotti Vincent J.Director, CHIEF EXECUTIVE OFFICER
TLPHTALPHERA, INC.
Open-market purchase
BUY$125K
213.3K sh
Mar 13, 2026Mar 25, 2026
traded Mar 13, 2026
+12dSEC FORM 4

Evidence

51
AS
Aslam ShakilChief Medical Officer
TLPHTALPHERA, INC.
Open-market purchase
BUY$28K
35.0K sh
Feb 12, 2026Feb 20, 2026
traded Feb 12, 2026
+8dSEC FORM 4

Evidence

19
AS
Aslam ShakilChief Medical Officer
TLPHTALPHERA, INC.
Grant or award
A—
205.0K sh
Feb 12, 2026Feb 20, 2026
traded Feb 12, 2026
+8dSEC FORM 4

Evidence

Angotti Vincent J.
Director, CHIEF EXECUTIVE OFFICER · Mar 25, 2026
  • ← Insider ofevidence
    Aslam ShakilChief Medical Officer · Feb 20, 2026